– World news selected by Gazette editors for Phuket’s international community
PHUKET: China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and ageing population.
Given the 10 years or more it typically takes to bring a new medicine to market, original “Made in China” treatments won’t arrive overnight, but multinationals are already encountering more competition from local generic drugs that look set for a quantum leap in quality.
The stakes are high. China is the world’s second biggest drugs market behind the United States, and fast food, smoking and pollution have fuelled a rise in cancers and chronic heart and lung diseases.
The country also has more diabetics than any other in the world, with numbers expected to hit 151 million by 2040 from 110 million today, according to the International Diabetes Federation.
That has made China a sweet spot for Denmark’s Novo Nordisk ; the world’s biggest insulin producer has mined a rich seam in the country since opening production facilities here in 1995.
By 2010, it dominated 63 percent of China’s insulin market. But it has recently been losing ground to local competitors cheered on by Beijing.
“China is going to be tough for us for the next couple of years,” said Chief Science Officer Mads Krogsgaard Thomsen. “Right now, the country is very focused on building domestic production.”
Local rivals are selling both cut-price basic insulin and sophisticated modern versions, including a biosimilar copy of Sanofi’s Lantus made by Chinese biotech specialist Gan & Lee Pharmaceuticals.
END OF BRANDED GENERICS?
Greater local competition is also evident in other areas, helping the top 10 Chinese drugmakers grow sales 12 percent on average this year, according to IMS Consulting – twice the rate of multinationals, which suffered a setback from a bribery scandal at GlaxoSmithKline two years ago.
GSK itself has seen its drug sales slump.
Increasing local competition is part of a structural upheaval in China’s hospital-dominated prescription drug market.
Selling drugs to patients at a hefty mark-up – especially off-patent Western “branded generics” – often accounts for 40-50 percent of Chinese hospitals’ revenues. But the authorities are now pushing a policy of zero mark-ups, initially in smaller county hospitals.
“Branded generics are something that exist today, but the need for them in 10 years time is not going to be there,” said Luke Miels, AstraZeneca’s global portfolio head.
That means foreign firms will be more reliant on new, patented medicines, although the scale of demand for such expensive products is uncertain in a country with only basic health insurance cover.
At the other end of the spectrum, multinationals aim to build up volume, often in partnership with local players, in the big markets outside China’s top cities, where distribution costs are high and prices low.
“It’s the right thing to do, even if profit margins shrink,” said the head of one big multinational.
Pivotal to the transformation of the market is the China Food and Drug Administration, led by reformist boss Bi Jingquan since January.
The watchdog has promised to speed up approval of innovative new drugs, which can take 5-7 years, while cracking down on substandard local generics.
“This creates lots of opportunities for local Chinese companies that have a strong focus on innovation,” said a spokesman for China’s Fosun Pharma, which sees itself among the winners.
It is not alone. A cluster of drug research labs in eastern Shanghai highlights the promise of China’s life sciences sector. The area brings together multinational and local firms, alongside contract research businesses and small biotech operations.
Among the latter is Hua Medicine, led by Chinese-born, Western-educated Chief Executive Li Chen, who used to run Roche’s China R&D centre. Now he is developing a novel diabetes treatment, licensed from Roche, while working on Hua’s own promising leads.
Another standard-bearer for Chinese biotech is Beijing-based cancer specialist BeiGene, which last month announced plans for a $100 million initial public offering on Nasdaq.
At a time when China’s academic researchers have grabbed headlines by editing the genes of human embryos, such start-ups highlight the commercial potential of China’s biotech know-how.
The history of failure in drug development suggests they won’t have an easy ride, but GSK’s China R&D head Min Li, a returnee from America, believes “there is a real chance for China to leap ahead in life sciences”.
Dennis Gillings, executive chairman of leading contract research organisation Quintiles, said the number of Chinese-developed drugs in the pipeline was rising fast.
“It’s probably been taking everyone a little by surprise, the sheer scale of that,” he said. “As we hit the next decade in the 2020s, I’d be very surprised if there wasn’t at least a top 20, if not top 10, global pharma player that was headquartered in China.”
— Phuket Gazette Editors
Get more from The Thaiger
Join the conversation and have your say on Thailand news published on The Thaiger.
Thaiger Talk is our new Thaiger Community where you can join the discussion on everything happening in Thailand right now.
Please note that articles are not posted to the forum instantly and can take up to 20 min before being visible. Click for more information and the Thaiger Talk Guidelines.
Mother seeks justice after a monk slapped her son
Bangkok ranked one of top 5 expat cities
Woman abandons home after police ignore four burglaries
VIDEO: Brave citizens save delivery driver swept away by floods in northeast Thailand
Chiang Mai wakes up to a flooded city district
Japanese warned to take cover over North Korea missile test
Book on Trump reveals casual racism and homophobia
Thai bank releases bizarre ‘apology’ for repossessing the wrong house
Thailand wants more tourists from Kazakhstan and Uzbekistan
Elon Musk angers Ukraine president with Russia tweets
Europeans arrested in Iran
Thai woman charged for selling fake discount vouchers
Expressway killer reveals 3 month plan to murder girlfriend in remorseless confession
Prayut plans to contact citizens hit by power cuts via radio
Submarine purchases could sink over engine debate
5 suit tailors in Bangkok that’ll make you look dapper
Things to do in Bangkok that cost next to nothing (2022)
VIDEO: 500 year old Buddhist stupa collapses in Chiang Mai revealing hidden treasures
Thailand’s strange laws – 10 strange laws in Thailand
Is the dream over? China walks back Belt & Road ambitions
OnlyFans star sentenced to six years in prison in Myanmar
Thailand’s weak baht could have a silver lining in the tourism industry, THA says
Woman’s body in luggage found floating in Mekong River
Thai baht plunges to 38 against US dollar for first time in 16 years
Canadian gangster in Phuket killing faces death penalty in Thailand
Snitching on parking space hoggers could earn you 5,000 baht in Thailand
20 baht notes printed with errors, says Bank of Thailand
Maya Bay reopens once again to the public
Thai lotto winners reward ghosts with pricey Japanese feast
Thailand to extend Smart Visa scheme to draw talent
Morning Top Stories Thailand | Police to end protests, Human Trafficking | September 14
Thailand News Today | Thai Airways in rehab, All go for Songkran | March 4
Phuket’s nightlife. Yes, bars and clubs are still open | VIDEO
Thailand News Today | Covid passport talks, Thai Airways heads to court | March 2
Phuket Thai food treats you need to try | VIDEO
Thailand News Today | Bars, pubs and restaurants ‘sort of’ back to normal | Feb 23
In search of Cat & Dog Cafés in Phuket Town | VIDEO
Thailand News Today | Gambling crackdown, Seafood market to reopen, Vlogger challenge | Jan 21
Thailand News Today | Covid testing for visas, Business impact, Vaccine approval | January 19
Thailand News Today | Weekend Bangkok bombs, Thailand fires, Covid update | January 18
Thailand News Today | Stray car on runway, Indonesian quake, 300 baht tourist fee | January 15
Thailand News Today | Governor off respirator, sex-trafficking arrest, condo prices falling | January 14
Thailand News Today | Chinese vaccine, Thailand ‘drug hub’, Covid update | January 13
Thailand News Today | Bangkok may ease restrictions, Phuket bar curfew, Vaccine roll out | January 12
Thailand News Today | Covid latest, Cockfights closed down, Bryde’s Whale beached | January 11
Environment1 day ago
Maya Bay reopens once again to the public
Thailand1 day ago
Thailand’s cold season expected to hit in late October
Bangkok3 days ago
Anti-Prayut rallies expected across Bangkok
Chiang Mai24 hours ago
River in Chiang Mai overflows, floods spread
Bangkok3 days ago
Garbage in canals worsens flooding in Bangkok
Property4 days ago
What $100,000 buys you for a condo in Bangkok, Phuket, Pattaya, Koh Samui and Hua Hin
North East1 day ago
30 trail runners stuck in Isaan forest due to flash flood
Thailand1 day ago
Bank repossesses the wrong house in central Thailand